table S5 from PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
收藏NIAID Data Ecosystem2026-05-17 收录
数据链接：
官方服务：
资源简介：
Phosphoproteins changes induced by PQR309 in B cell lymphoma cell lines revealed using Pathscan Akt Signaling Antibody Array Kit.
创建时间：
2018-01-01
